Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182


Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR.

Diabetes Technol Ther. 2012 Mar;14(3):205-9. doi: 10.1089/dia.2011.0292.


The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.

Brazg RL, Bailey TS, Garg S, Buckingham BA, Slover RH, Klonoff DC, Nguyen X, Shin J, Welsh JB, Lee SW.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1466-71.


The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.

Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2014 Jun;16(6):338-47. doi: 10.1089/dia.2013.0327.


Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.

Garg SK, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR.

Diabetes Technol Ther. 2014 Mar;16(3):125-30. doi: 10.1089/dia.2013.0219.


Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.

Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR.

J Diabetes Sci Technol. 2011 Sep 1;5(5):1137-41.


Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.

Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A.

Diabetes Technol Ther. 2011 Nov;13(11):1129-34. doi: 10.1089/dia.2011.0084.


The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study.

Zhou J, Lv X, Mu Y, Wang X, Li J, Zhang X, Wu J, Bao Y, Jia W.

Diabetes Technol Ther. 2012 Aug;14(8):710-8. doi: 10.1089/dia.2012.0014.


Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.

Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW.

Diabetes Care. 2012 Jul;35(7):1462-5. doi: 10.2337/dc12-0052.


Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group..

N Engl J Med. 2013 Jul 18;369(3):224-32. doi: 10.1056/NEJMoa1303576.


Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.


Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.

Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW.

JAMA. 2013 Sep 25;310(12):1240-7. doi: 10.1001/jama.2013.277818.


Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.

Peyser TA, Nakamura K, Price D, Bohnett LC, Hirsch IB, Balo A.

Diabetes Technol Ther. 2015 Aug;17(8):548-54. doi: 10.1089/dia.2014.0415.


ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.

Klonoff DC, Bergenstal RM, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann A, Welsh JB, Lee SW.

J Diabetes Sci Technol. 2013 Jul 1;7(4):1005-10.


Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy.

Gomez AM, Gomez C, Aschner P, Veloza A, Muñoz O, Rubio C, Vallejo S.

J Diabetes Sci Technol. 2015 May;9(3):619-24. doi: 10.1177/1932296814566233.


The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.

Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T.

Pediatr Diabetes. 2013 May;14(3):159-67. doi: 10.1111/pedi.12025.


Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.

Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA.

Diabetes Care. 2011 Sep;34(9):2023-5. doi: 10.2337/dc10-2411.


Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.

Harvey RA, Dassau E, Bevier WC, Seborg DE, Jovanovič L, Doyle FJ 3rd, Zisser HC.

Diabetes Technol Ther. 2014 Jun;16(6):348-57. doi: 10.1089/dia.2013.0231.


The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes.

Stenerson M, Cameron F, Payne SR, Payne SL, Ly TT, Wilson DM, Buckingham BA.

J Diabetes Sci Technol. 2015 Jan;9(1):80-5. doi: 10.1177/1932296814551045.


Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.

Weiss R, Garg SK, Bergenstal RM, Klonoff DC, Bode BW, Bailey TS, Thrasher J, Schwartz F, Welsh JB, Kaufman FR; ASPIRE In-Home Study Group..

J Diabetes Sci Technol. 2015 May 18;9(5):1016-20. doi: 10.1177/1932296815586014.


Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.

Sherr JL, Palau Collazo M, Cengiz E, Michaud C, Carria L, Steffen AT, Weyman K, Zgorski M, Tichy E, Tamborlane WV, Weinzimer SA.

Diabetes Care. 2014;37(3):773-9. doi: 10.2337/dc13-1608.

Items per page

Supplemental Content

Support Center